Literature DB >> 1206096

The response of pancreatic and pituitary hormones to pulses and constant infusion of somatostatin.

H Leblanc, L A Rigg, S S Yen.   

Abstract

The inhibitory action of pulses and constant infusion of somatostatin on the secretion of pancreatic and pituitary hormones was studied serially in 7 normal men and 2 untreated acromegalics. In normal men, significant inhibition of basal release of insulin and glucagon was elicited by as little as 1 mug dose of a pulse of somatostatin. Increasing doses of somatostatin (5, 50, 250 and 500 mug) given as a single pulse at weekly intervals produced what appears to be a decreased inhibition of glucagon while no measurable relationship between the dose of somatostatin and the degree of inhibition of insulin was seen. Given during the same day, incremental doses (from 1 to 250 mug) of pulses of somatostain produced a progressive decline in both glucagon and insulin. The elevated basal levels of GH, insulin and glucagon seen in acromegalics, were inhibited by a pulse of somatostatin as little as 2 mug. These inhibitions were sustained during the constant infusion of somatostatin (2.5 mug/min), and a rebound in GH, insulin and glucagon appeared promptly following the infusion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1206096     DOI: 10.1210/jcem-41-6-1105

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Effects of somatostatin in a case of severe hypoglycemia due to nesidioblastosis.

Authors:  E Roti; C Ghinelli; P Bandini; C Del Rossi; R Emanuele; G Robuschi; A Gnudi
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

2.  Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.

Authors:  E Lien; D Sarantakis
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.